Saphnelo 150 mg

SAPHNELO 150 MG is an intravenous solution containing anifrolumab, a medication used to manage moderate to severe conditions. This prescription-only treatment is designed for specific therapeutic uses under medical supervision.

SAPHNELO 150 MG is primarily used for the treatment of moderate to severe conditions that require targeted therapy. Anifrolumab, the active ingredient, is often prescribed for conditions that involve immune system regulation. Patients typically use this medication as part of a broader treatment plan, following their healthcare provider's instructions.

Common effects of SAPHNELO 150 MG may include temporary discomfort at the injection site, fatigue, and mild flu-like symptoms. Some individuals may experience changes in blood cell counts, which are usually monitored by a healthcare professional. It's important to discuss any persistent or severe effects with a medical provider.

SAPHNELO 150 MG should be administered under the supervision of a healthcare professional. Patients with a history of severe allergic reactions or certain infections should inform their doctor before starting treatment. Regular monitoring may be required to assess the medication's impact on the immune system and overall health.

SAPHNELO 150 MG may interact with other medications that affect the immune system or blood cell counts. It's important to inform your healthcare provider about all current medications, including over-the-counter drugs and supplements. Alcohol and certain foods may also influence the medication's effectiveness, so it's advisable to follow a healthcare provider's guidance.